Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 231 entries
Sorted by: Best Match Show Resources per page
Response to Dr Caballero-Mora's comments.

Age and ageing

Lavan AH, O'Mahony D, Gallagher P.
PMID: 28874009
Age Ageing. 2017 Sep 01;46(5):875. doi: 10.1093/ageing/afx138.

No abstract available.

Cite
Lavan AH, O'Mahony D, Gallagher P. Response to Dr Caballero-Mora's comments. Age Ageing. 2017;46(5):875doi: 10.1093/ageing/afx138.
Lavan, A. H., O'Mahony, D., & Gallagher, P. (2017). Response to Dr Caballero-Mora's comments. Age and ageing, 46(5), 875. https://doi.org/10.1093/ageing/afx138
Lavan, Amanda Hanora, et al. "Response to Dr Caballero-Mora's comments." Age and ageing vol. 46,5 (2017): 875. doi: https://doi.org/10.1093/ageing/afx138
Lavan AH, O'Mahony D, Gallagher P. Response to Dr Caballero-Mora's comments. Age Ageing. 2017 Sep 01;46(5):875. doi: 10.1093/ageing/afx138. PMID: 28874009.
Copy Download .nbib Format: NLM
Exact propagator for generalized Ornstein-Uhlenbeck processes.

Physical review. E, Statistical, nonlinear, and soft matter physics

Mota-Furtado F, O'Mahony PF.
PMID: 17500860
Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Apr;75(4):041102. doi: 10.1103/PhysRevE.75.041102. Epub 2007 Apr 02.

A closed form expression for the propagator is derived, in terms of modified Bessel functions, for the Fokker-Planck equation for a physically important generalization of the Ornstein-Uhlenbeck process where the diffusion constant D(p) is a function of the momentum....

Cite
Mota-Furtado F, O'Mahony PF. Exact propagator for generalized Ornstein-Uhlenbeck processes. Phys Rev E Stat Nonlin Soft Matter Phys. 2007;75(4):041102doi: 10.1103/PhysRevE.75.041102.
Mota-Furtado, F., & O'Mahony, P. F. (2007). Exact propagator for generalized Ornstein-Uhlenbeck processes. Physical review. E, Statistical, nonlinear, and soft matter physics, 75(4), 041102. https://doi.org/10.1103/PhysRevE.75.041102
Mota-Furtado, F, and O'Mahony, P F. "Exact propagator for generalized Ornstein-Uhlenbeck processes." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 75,4 (2007): 041102. doi: https://doi.org/10.1103/PhysRevE.75.041102
Mota-Furtado F, O'Mahony PF. Exact propagator for generalized Ornstein-Uhlenbeck processes. Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Apr;75(4):041102. doi: 10.1103/PhysRevE.75.041102. Epub 2007 Apr 02. PMID: 17500860.
Copy Download .nbib Format: NLM
What's in a Name? Can Mullein Weed Beat TB Where Modern Drugs Are Failing?.

Evidence-based complementary and alternative medicine : eCAM

McCarthy E, O'Mahony JM.
PMID: 20953419
Evid Based Complement Alternat Med. 2011;2011. doi: 10.1155/2011/239237. Epub 2010 Sep 19.

Common mullein weed (Verbascum thapsus) has a large number of synonyms and old local "nick names" which connect the plant with mycobacteria. A strong history of medicinal use has been uncovered for the treatment of tuberculosis, tubercular skin disease,...

Cite
McCarthy E, O'Mahony JM. What's in a Name? Can Mullein Weed Beat TB Where Modern Drugs Are Failing?. Evid Based Complement Alternat Med. 2010;2011doi: 10.1155/2011/239237.
McCarthy, E., & O'Mahony, J. M. (2011). What's in a Name? Can Mullein Weed Beat TB Where Modern Drugs Are Failing?. Evidence-based complementary and alternative medicine : eCAM, 2011. https://doi.org/10.1155/2011/239237
McCarthy, Eibhlín, and O'Mahony, Jim M. "What's in a Name? Can Mullein Weed Beat TB Where Modern Drugs Are Failing?." Evidence-based complementary and alternative medicine : eCAM vol. 2011 (2011). doi: https://doi.org/10.1155/2011/239237
McCarthy E, O'Mahony JM. What's in a Name? Can Mullein Weed Beat TB Where Modern Drugs Are Failing?. Evid Based Complement Alternat Med. 2011;2011. doi: 10.1155/2011/239237. Epub 2010 Sep 19. PMID: 20953419; PMCID: PMC2952292.
Copy Download .nbib Format: NLM
Rapid field identification of subjects involved in firearm-related crimes based on electroanalysis coupled with advanced chemometric data treatment.

Analytical chemistry

Cetó X, O'Mahony AM, Samek IA, Windmiller JR, del Valle M, Wang J.
PMID: 23121395
Anal Chem. 2012 Dec 04;84(23):10306-14. doi: 10.1021/ac302361z. Epub 2012 Nov 12.

We demonstrate a novel system for the detection and discrimination of varying levels of exposure to gunshot residue from subjects in various control scenarios. Our aim is to address the key challenge of minimizing the false positive identification of...

Cite
Cetó X, O'Mahony AM, Samek IA, et al. Rapid field identification of subjects involved in firearm-related crimes based on electroanalysis coupled with advanced chemometric data treatment. Anal Chem. 2012;84(23):10306-14doi: 10.1021/ac302361z.
Cetó, X., O'Mahony, A. M., Samek, I. A., Windmiller, J. R., del Valle, M., & Wang, J. (2012). Rapid field identification of subjects involved in firearm-related crimes based on electroanalysis coupled with advanced chemometric data treatment. Analytical chemistry, 84(23), 10306-14. https://doi.org/10.1021/ac302361z
Cetó, Xavier, et al. "Rapid field identification of subjects involved in firearm-related crimes based on electroanalysis coupled with advanced chemometric data treatment." Analytical chemistry vol. 84,23 (2012): 10306-14. doi: https://doi.org/10.1021/ac302361z
Cetó X, O'Mahony AM, Samek IA, Windmiller JR, del Valle M, Wang J. Rapid field identification of subjects involved in firearm-related crimes based on electroanalysis coupled with advanced chemometric data treatment. Anal Chem. 2012 Dec 04;84(23):10306-14. doi: 10.1021/ac302361z. Epub 2012 Nov 12. PMID: 23121395.
Copy Download .nbib Format: NLM
Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.

International journal of hepatology

Harring TR, Nguyen NT, Goss JA, O'Mahony CA.
PMID: 22013537
Int J Hepatol. 2011;2011:154541. doi: 10.4061/2011/154541. Epub 2011 Oct 13.

Patients diagnosed with Neuroendocrine Tumors (NET) often are also diagnosed with Neuroendocrine Liver Metastases (NLM) during the course of their disease. NLM can cause significant morbidity and mortality, oftentimes much more than compared to patients with NET. Treatment options...

Cite
Harring TR, Nguyen NT, Goss JA, et al. Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. Int J Hepatol. 2011;2011:154541doi: 10.4061/2011/154541.
Harring, T. R., Nguyen, N. T., Goss, J. A., & O'Mahony, C. A. (2011). Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. International journal of hepatology, 2011154541. https://doi.org/10.4061/2011/154541
Harring, Theresa R, et al. "Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review." International journal of hepatology vol. 2011 (2011): 154541. doi: https://doi.org/10.4061/2011/154541
Harring TR, Nguyen NT, Goss JA, O'Mahony CA. Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. Int J Hepatol. 2011;2011:154541. doi: 10.4061/2011/154541. Epub 2011 Oct 13. PMID: 22013537; PMCID: PMC3195553.
Copy Download .nbib Format: NLM
Resonant optical second harmonic generation at the steps of vicinal Si(001).

Physical review letters

Chandola S, McGilp JF, O'Mahony JD, Power JR.
PMID: 10060215
Phys Rev Lett. 1995 Aug 07;75(6):1138-1141. doi: 10.1103/PhysRevLett.75.1138.

No abstract available.

Cite
Chandola S, McGilp JF, O'Mahony JD, et al. Resonant optical second harmonic generation at the steps of vicinal Si(001). Phys Rev Lett. 1995;75(6):1138-1141doi: 10.1103/PhysRevLett.75.1138.
Chandola, S., McGilp, J. F., O'Mahony, J. D., & Power, J. R. (1995). Resonant optical second harmonic generation at the steps of vicinal Si(001). Physical review letters, 75(6), 1138-1141. https://doi.org/10.1103/PhysRevLett.75.1138
Chandola, et al. "Resonant optical second harmonic generation at the steps of vicinal Si(001)." Physical review letters vol. 75,6 (1995): 1138-1141. doi: https://doi.org/10.1103/PhysRevLett.75.1138
Chandola S, McGilp JF, O'Mahony JD, Power JR. Resonant optical second harmonic generation at the steps of vicinal Si(001). Phys Rev Lett. 1995 Aug 07;75(6):1138-1141. doi: 10.1103/PhysRevLett.75.1138. PMID: 10060215.
Copy Download .nbib Format: NLM
ExpoQual: Evaluating measured and modeled human exposure data.

Environmental research

LaKind JS, O'Mahony C, Armstrong T, Tibaldi R, Blount BC, Naiman DQ.
PMID: 30708234
Environ Res. 2019 Apr;171:302-312. doi: 10.1016/j.envres.2019.01.039. Epub 2019 Jan 25.

Recent rapid technological advances are producing exposure data sets for which there are no available data quality assessment tools. At the same time, regulatory agencies are moving in the direction of data quality assessment for environmental risk assessment and...

Cite
LaKind JS, O'Mahony C, Armstrong T, et al. ExpoQual: Evaluating measured and modeled human exposure data. Environ Res. 2019;171:302-312doi: 10.1016/j.envres.2019.01.039.
LaKind, J. S., O'Mahony, C., Armstrong, T., Tibaldi, R., Blount, B. C., & Naiman, D. Q. (2019). ExpoQual: Evaluating measured and modeled human exposure data. Environmental research, 171302-312. https://doi.org/10.1016/j.envres.2019.01.039
LaKind, Judy S, et al. "ExpoQual: Evaluating measured and modeled human exposure data." Environmental research vol. 171 (2019): 302-312. doi: https://doi.org/10.1016/j.envres.2019.01.039
LaKind JS, O'Mahony C, Armstrong T, Tibaldi R, Blount BC, Naiman DQ. ExpoQual: Evaluating measured and modeled human exposure data. Environ Res. 2019 Apr;171:302-312. doi: 10.1016/j.envres.2019.01.039. Epub 2019 Jan 25. PMID: 30708234.
Copy Download .nbib Format: NLM
Ultrafast Relaxation of Symmetry-Breaking Photo-Induced Atomic Forces.

Physical review letters

O'Mahony SM, Murphy-Armando F, Murray ÉD, Querales-Flores JD, Savić I, Fahy S.
PMID: 31491230
Phys Rev Lett. 2019 Aug 23;123(8):087401. doi: 10.1103/PhysRevLett.123.087401.

We present a first-principles method for the calculation of the temperature-dependent relaxation of symmetry-breaking atomic driving forces in photoexcited systems. We calculate the phonon-assisted decay of the photoexcited force on the low-symmetry E_{g} mode following absorption of an ultrafast...

Cite
O'Mahony SM, Murphy-Armando F, Murray ÉD, et al. Ultrafast Relaxation of Symmetry-Breaking Photo-Induced Atomic Forces. Phys Rev Lett. 2019;123(8):087401doi: 10.1103/PhysRevLett.123.087401.
O'Mahony, S. M., Murphy-Armando, F., Murray, �. �. D., Querales-Flores, J. D., Savić, I., & Fahy, S. (2019). Ultrafast Relaxation of Symmetry-Breaking Photo-Induced Atomic Forces. Physical review letters, 123(8), 087401. https://doi.org/10.1103/PhysRevLett.123.087401
O'Mahony, Shane M, et al. "Ultrafast Relaxation of Symmetry-Breaking Photo-Induced Atomic Forces." Physical review letters vol. 123,8 (2019): 087401. doi: https://doi.org/10.1103/PhysRevLett.123.087401
O'Mahony SM, Murphy-Armando F, Murray ÉD, Querales-Flores JD, Savić I, Fahy S. Ultrafast Relaxation of Symmetry-Breaking Photo-Induced Atomic Forces. Phys Rev Lett. 2019 Aug 23;123(8):087401. doi: 10.1103/PhysRevLett.123.087401. PMID: 31491230.
Copy Download .nbib Format: NLM
The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia.

Pilot and feasibility studies

Skinner MW, Chai-Adisaksopha C, Curtis R, Frick N, Nichol M, Noone D, O'Mahony B, Page D, Stonebraker JS, Iorio A.
PMID: 29497561
Pilot Feasibility Stud. 2018 Feb 27;4:58. doi: 10.1186/s40814-018-0253-0. eCollection 2018.

BACKGROUND: The interest of health care agencies, private payers and policy makers for patient-reported outcomes (PRO) is continuously increasing. There is a substantial need to improve capacity to collect and interpret relevant PRO data to support implementation of patient-centered...

Cite
Skinner MW, Chai-Adisaksopha C, Curtis R, et al. The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia. Pilot Feasibility Stud. 2018;4:58doi: 10.1186/s40814-018-0253-0.
Skinner, M. W., Chai-Adisaksopha, C., Curtis, R., Frick, N., Nichol, M., Noone, D., O'Mahony, B., Page, D., Stonebraker, J. S., & Iorio, A. (2018). The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia. Pilot and feasibility studies, 458. https://doi.org/10.1186/s40814-018-0253-0
Skinner, M W, et al. "The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia." Pilot and feasibility studies vol. 4 (2018): 58. doi: https://doi.org/10.1186/s40814-018-0253-0
Skinner MW, Chai-Adisaksopha C, Curtis R, Frick N, Nichol M, Noone D, O'Mahony B, Page D, Stonebraker JS, Iorio A. The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia. Pilot Feasibility Stud. 2018 Feb 27;4:58. doi: 10.1186/s40814-018-0253-0. eCollection 2018. PMID: 29497561; PMCID: PMC5828307.
Copy Download .nbib Format: NLM
Eliminating Panglossian thinking in development of AAV therapeutics.

Molecular therapy : the journal of the American Society of Gene Therapy

Kaczmarek R, Pierce GF, Noone D, O'Mahony B, Page D, Skinner MW.
PMID: 34758292
Mol Ther. 2021 Dec 01;29(12):3325-3327. doi: 10.1016/j.ymthe.2021.10.025. Epub 2021 Nov 10.

No abstract available.

Cite
Kaczmarek R, Pierce GF, Noone D, et al. Eliminating Panglossian thinking in development of AAV therapeutics. Mol Ther. 2021;29(12):3325-3327doi: 10.1016/j.ymthe.2021.10.025.
Kaczmarek, R., Pierce, G. F., Noone, D., O'Mahony, B., Page, D., & Skinner, M. W. (2021). Eliminating Panglossian thinking in development of AAV therapeutics. Molecular therapy : the journal of the American Society of Gene Therapy, 29(12), 3325-3327. https://doi.org/10.1016/j.ymthe.2021.10.025
Kaczmarek, Radoslaw, et al. "Eliminating Panglossian thinking in development of AAV therapeutics." Molecular therapy : the journal of the American Society of Gene Therapy vol. 29,12 (2021): 3325-3327. doi: https://doi.org/10.1016/j.ymthe.2021.10.025
Kaczmarek R, Pierce GF, Noone D, O'Mahony B, Page D, Skinner MW. Eliminating Panglossian thinking in development of AAV therapeutics. Mol Ther. 2021 Dec 01;29(12):3325-3327. doi: 10.1016/j.ymthe.2021.10.025. Epub 2021 Nov 10. PMID: 34758292; PMCID: PMC8636166.
Copy Download .nbib Format: NLM
Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging.

European heart journal. Cardiovascular Imaging

Rosmini S, Seraphim A, Knott K, Brown JT, Knight DS, Zaman S, Cole G, Sado D, Captur G, Gomes AC, Zemrak F, Treibel TA, Cash L, Culotta V, O'Mahony C, Kellman P, Moon JC, Manisty C.
PMID: 34331054
Eur Heart J Cardiovasc Imaging. 2021 Jul 30; doi: 10.1093/ehjci/jeab128. Epub 2021 Jul 30.

AIMS: Differentiating exudative from transudative effusions is clinically important and is currently performed via biochemical analysis of invasively obtained samples using Light's criteria. Diagnostic performance is however limited. Biochemical composition can be measured with T1 mapping using cardiovascular magnetic...

Cite
Rosmini S, Seraphim A, Knott K, et al. Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging. Eur Heart J Cardiovasc Imaging. 2021;doi: 10.1093/ehjci/jeab128.
Rosmini, S., Seraphim, A., Knott, K., Brown, J. T., Knight, D. S., Zaman, S., Cole, G., Sado, D., Captur, G., Gomes, A. C., Zemrak, F., Treibel, T. A., Cash, L., Culotta, V., O'Mahony, C., Kellman, P., Moon, J. C., & Manisty, C. (2021). Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging. European heart journal. Cardiovascular Imaging, . https://doi.org/10.1093/ehjci/jeab128
Rosmini, Stefania, et al. "Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging." European heart journal. Cardiovascular Imaging vol. (2021). doi: https://doi.org/10.1093/ehjci/jeab128
Rosmini S, Seraphim A, Knott K, Brown JT, Knight DS, Zaman S, Cole G, Sado D, Captur G, Gomes AC, Zemrak F, Treibel TA, Cash L, Culotta V, O'Mahony C, Kellman P, Moon JC, Manisty C. Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging. Eur Heart J Cardiovasc Imaging. 2021 Jul 30; doi: 10.1093/ehjci/jeab128. Epub 2021 Jul 30. PMID: 34331054.
Copy Download .nbib Format: NLM
Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability.

The European journal of health economics : HEPAC : health economics in prevention and care

Almajed S, Alotaibi N, Zulfiqar S, Dhuhaibawi Z, O'Rourke N, Gaule R, Byrne C, Barry AM, Keeley D, O'Mahony JF.
PMID: 34460007
Eur J Health Econ. 2021 Aug 30; doi: 10.1007/s10198-021-01365-2. Epub 2021 Aug 30.

BACKGROUND: We surveyed evidence published by Ireland's National Centre for Pharmacoeconomics (NCPE) on the cost-effectiveness of cancer drugs approved for funding within the Irish public healthcare system. The purpose is threefold: to assess the completeness and clarity of publicly...

Cite
Almajed S, Alotaibi N, Zulfiqar S, et al. Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability. Eur J Health Econ. 2021;doi: 10.1007/s10198-021-01365-2.
Almajed, S., Alotaibi, N., Zulfiqar, S., Dhuhaibawi, Z., O'Rourke, N., Gaule, R., Byrne, C., Barry, A. M., Keeley, D., & O'Mahony, J. F. (2021). Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability. The European journal of health economics : HEPAC : health economics in prevention and care, . https://doi.org/10.1007/s10198-021-01365-2
Almajed, Suaad, et al. "Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability." The European journal of health economics : HEPAC : health economics in prevention and care vol. (2021). doi: https://doi.org/10.1007/s10198-021-01365-2
Almajed S, Alotaibi N, Zulfiqar S, Dhuhaibawi Z, O'Rourke N, Gaule R, Byrne C, Barry AM, Keeley D, O'Mahony JF. Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability. Eur J Health Econ. 2021 Aug 30; doi: 10.1007/s10198-021-01365-2. Epub 2021 Aug 30. PMID: 34460007.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 231 entries